Precedo Healthcare Services Limited Filleted accounts for Companies House (small and micro)

Precedo Healthcare Services Limited

Unaudited financial statements

31 October 2025

Company Registration Number 6675933

Precedo Healthcare Services Limited

Financial statements

year ended 31 October 2025

Contents	Pages

Officers and professional advisers	1

Balance sheet	2 to 3

Notes to the financial statements	4 to 6

Precedo Healthcare Services Limited

Officers and professional advisers

Director	Mr C J Webster

Registered office	Unit 5
	Stubley Works
	Wreakes Lane
	Dronfield

Accountants	darbys limited
	chartered certified accountants
	New Quorn House
	41 Potter Street
	Worksop
	Nottinghamshire

Precedo Healthcare Services Limited

Balance sheet

31 October 2025

	2025	2024
Note	£	£

Fixed assets

Tangible assets	5	69,734	48,235

Current assets

Debtors	6	344,621	303,427
Cash at bank and in hand		16,651	64,642
		---------	---------
		361,272	368,069

Prepayments and accrued income	52,724	62,250

Creditors: amounts falling due within one year	7	( 219,826)	( 189,201)
		---------	---------
Net current assets		194,170	241,118
		---------	---------
Total assets less current liabilities		263,904	289,353

Accruals and deferred income	( 71,294)	( 76,014)
	---------	---------
Net assets	192,610	213,339
	---------	---------

Precedo Healthcare Services Limited

Balance sheet (continued)

31 October 2025

	2025	2024
Note	£	£

Capital and reserves

Called up share capital	100	100
Profit and loss account	192,510	213,239
	---------	---------
Shareholders funds	192,610	213,339
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 15 July 2026 , and are signed on behalf of the board by:

Mr C J Webster
Director

Company registration number: 6675933

Precedo Healthcare Services Limited

Notes to the financial statements

year ended 31 October 2025

1. General information

The company is a private company limited by shares, registered in England. The address of the registered office is Unit 5, Stubley Works, Wreakes Lane, Dronfield.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

3.1 Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

3.2 Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

3.3 Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

3.4 Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Motor vehicles	-	25% reducing balance
Office equipment	-	20% reducing balance

3.5 Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 140 (2024: 152 ).

5. Tangible assets

Motor vehicles	Equipment	Total
£	£	£

Cost
At 1 November 2024	66,335	69,629	135,964
Additions	–	34,919	34,919
	--------	---------	---------
At 31 October 2025	66,335	104,548	170,883
	--------	---------	---------
Depreciation
At 1 November 2024	26,771	60,958	87,729
Charge for the year	9,891	3,529	13,420
	--------	---------	---------
At 31 October 2025	36,662	64,487	101,149
	--------	---------	---------
Carrying amount
At 31 October 2025	29,673	40,061	69,734
	--------	---------	---------
At 31 October 2024	39,564	8,671	48,235
	--------	---------	---------

6. Debtors

	2025	2024
	£	£

Trade debtors	223,306	236,351
Other debtors	121,315	67,076
	---------	---------
	344,621	303,427
	---------	---------

7. Creditors: amounts falling due within one year

	2025	2024
	£	£

Bank loans and overdrafts	136,946	103,004
Trade creditors	14,298	16,683
Corporation tax	2	2
Social security and other taxes	67,866	68,284
Other creditors	714	1,228
	---------	---------
	219,826	189,201
	---------	---------

Creditors falling due within one year includes a balance of £136,945 (2024 - £103,004) relating to invoice financing on which security has been given by the company.

8. Director's advances, credits and guarantees

Included in other debtors is an amount of £nil(2024 - £65,001) due to the company from the directors. This was repaid within nine months of the year end and no interest was charged.

9. Related party transactions

During the year a loan was made to Mayfield Alpacas Farm and Animal Sanctuary Limited of £121,314 (2024 - Nil) of which Mr C Webster is sole director and shareholder.